Background: Timely intervention in the treatment of bloodstream infection is important for prescription of appropriate antimicrobials. With prompt determination of the antimicrobial susceptibility of a causative agent, rapid antimicrobial susceptibility test (AST) can help select the appropriate antimicrobial therapy. This clinical study is for evaluation of the clinical performance of the QMAC-dRAST for rapid AST directly from positive blood culture (PBC)s with Gram-positive cocci. Methods: A total of 115 PBC samples with Grampositive organisms (76 Staphylococcus spp. and 39 Enterococcus spp.) were evaluated by the QMACdRAST system, and their pure culture isolates were evaluated by the MicroScan WalkAway (Beckman Coulter, USA) as the comparative AST system. Thirteen antimicrobial agents were included, and the agreement and discrepancy rates of the QMACdRAST system (Quantamatrix Inc., Republic of Korea) compared to the MicroScan WalkAway were calculated. To resolve discrepancies, the broth microdilution method was performed.
INTRODUCTION
Timely intervention in the treatment of bloodstream infection is of high significance to provide precise antimicrobial [1, 2] .
With prompt determination of antimicrobial susceptibility of causative agent, rapid AST can help selecting appropriate antimicrobial therapy. Furthermore, it is expected that rapid antimicrobial susceptibility test (AST) can contribute to the decrease of redundant laboratory tests, healthcare-associated expenses and prevention of empirical therapy [3] [4] [5] . In most of These conventional AST methods require relatively longer turnaround time (TAT) due to preceding preparation procedures including blood culture, Gram stain and overnight subculture onto solid medium of flagged positive culture samples [6] . For reducing TAT, various researchers have tried to directly process the positive blood culture (PBC) samples without subculture involving overnight culture [7] . AST methods utilizing direct inoculation from PBC had previously been reported with significant agreement rates compared to reference methods [8, 9] .
However, these previous studies reported that direct AST methods were insufficient to handle Gram-positive bacteria, mainly applicable for Gram-negative organisms [10] [11] [12] . The QMAC-dRAST (Quantamatrix Inc., Seoul, Republic of Korea) system has been introduced in the clinical microbiology laboratory for expedite treatment of bloodstream infection and antibiotic-resistant strain infections via a direct inoculation of PBC [13] . This system determines the antimicrobial susceptibility of bacteria within six hours without performing any additional separation processes and inoculum size measurement [13] [14] [15] .
The objective of this study was to evaluate the accuracy of QMAC-dRAST AST system with faster protocol for staphylococci and enterococci cocci isolates originated from blood culture bottles. The accuracy was compared to that from MicroScan WalkAway plus system, commonly used as an automated AST system.
MATERIALS AND METHODS

Samples
The clinical evaluation of this study was conducted from June 2015 to June 2016 at Seoul National University Hospital (SNUH). For blood culture, BACTEC Plus Aerobic/F and Anaerobic/F culture bottles were used in BACTEC FX automated incubation system (Becton Dickinson Company, NJ, USA) and BacT/Alert FA Plus and SN bottles in a BacT/Alert 3D system (bioMerieux Inc., Marcy l'Étoile, France). PBC samples containing mono-bacterial infection with staphylococci and enterococci were included in the study. The PBC samples identified as Gram-negative rod, yeast and Streptococcus spp. were excluded from this study.
Quality control strains
Quality control testing of QMAC-dRAST panels was conducted when they were manufactured at the factory and delivered to the laboratory. For the quality control organisms, E. faecalis ATCC 29212 and S. aureus ATCC 29213 strains were used.
QMAC-dRAST system as the direct and rapid AST
A PBC sample was collected from the positive-flagged blood bottle with a 1 mL syringe and transferred to a sterile tube without any additional process. To achieve the optimum inoculation concentration for the QMAC-dRAST system, a 10 μL of the PBC sample was mixed with 4 mL of liquid-state 0.5% agarose 
MicroScan WalkAway plus system
For comparative data, MicroScan WalkAway plus system was processed in parallel with QMAC-dRAST system. A drop of PBC sample was inoculated onto blood agar plate. The inoculated blood agar plates were incubated at 35°C in 5% CO2 to enable bacterial growth. After 20 hours incubation, the bacterial colonies were formed on the agar plate of a pure culture, as clinical isolates.
Broth microdilution (BMD) method as the confirmatory AST
The BMD method, recommended by CLSI, was used as a reference method to establish consensus categorical and MIC dis- crepancies occurred between the QMAC-dRAST system and MicroScan WalkAway plus system for each organism-antimicrobial combination [16] . For the BMD method, the antibiotic solutions were prepared from the stock solution. The antimicrobial agents at the appropriate concentration, which was determined by CLSI recommendation, were loaded on the bottom of 96 microwell plates (SPL Life Sciences, Pocheon, Korea).
After preparation of the BMD panel, 10 μL of clinical isolates at a final concentration of 5×10 5 CFU/mL was inoculated into well. The BMD tests were performed in triplicate. After [16] [17] [18] [19] [20] hours of incubation at 35°C, the MIC value of the BMD tests was determined as the concentration of the complete inhibition in growth as compared to the control. In case of results from erythromycin, linezolid, and tetracycline, MIC was determined in the lowest concentration where the trailing growth began [16] . For trimethoprim/sulfamethoxazole, MIC was the concentration in which there is ≥80% reduction in growth as compared to the control [16] .
Identification of bacteria from PBC bottles
For the analysis of bacterial identification, a PBC sample was 
Data analysis
The MIC values analyzed from the QMAC-dRAST system and BMD method were translated into clinical categories gallinarum. These GPC isolates were used for interpreting MIC and interpretative AST results.
The performance of the QMAC-dRAST system
The AST results of the QMAC-dRAST system for Gram-positive cocci from 115 (1,187 antimicrobial agent-microorganism combinations) PBC samples are shown in the Table 2 . For 115
Gram-positive samples, through the QMAC-dRAST system, we observed 94.9% of CA and 98.3% of EA between QMAC-RAST system and MicroScan WalkAway plus system, respectively. The discrepancy rates of QMAC-dRAST were VME of 1.0% (5/485), ME of 1.2% (9/693) and mE of 4.0%
(47/1,187), respectively. The highest CA was observed from ampicillin (100%), followed by linezolid (99.1%). Lowest CA was shown from erythromycin (84.3%) and ciprofloxacin (89.6%). The QMAC-dRAST system yielded over 90% of CA for each antimicrobial except two antimicrobial agents; erythromycin and ciprofloxacin. The majority of discrepancies was classified as mEs.
The discrepancy rates for to QMAC-dRAST results compared to those from MicroScan WalkAway plus system in species level are shown in and mEs occurred mostly from ciprofloxacin, gentamicin, erythromycin, and vancomycin. For Enterococcus spp., no VME and ME were found, however, mE were mostly observed from erythromycin and vancomycin. All vancomycin-resistant Enterococcus were detected as resistant by the QMAC-dRAST system.
In overall, mE accounted for the most of errors from the tests with all antimicrobial agents ( Table 3 ).
The QMAC-dRAST results were available within 6 hours after inoculation into the QMAC-dRAST GP panel, which were concordant with previous research [13] .
DISCUSSION
Rapid and accurate antimicrobial prescription is essential for successful management of BSI patients. In general, antimicrobial regimens are empirically chosen until AST results are available.
Since empirical broad-spectrum antimicrobial treatment could induce the emergence of antimicrobial resistant microorganisms, it is important for clinicians to prescribe requisite antibiotics for reduction of mortality and morbidity. Faster identification of antimicrobial susceptibility can reduce TAT via expediting appropriate antimicrobial choices. Through expedite antibiotic profiling, patient management can be further improved by reducing numbers of redundant laboratory tests and procedures [5] . As the current AST systems necessitate longer TAT and manual procedures, there needs automated form of rapid AST system for both reducing TAT and redundant procedures [17] .
However, the antimicrobial prescription process using current automated AST system takes more than two days from existence of causative agents in blood culture bottle, involving sequential experimental step; sub-culture to form the colony from the PBC samples and to perform conventional AST. To accelerate this process, many research groups have focused on the development of methodology by directly applying the PBCs into the current AST system.
One experimental approach has utilized inoculum directly from PBCs for AST, rather than cultured microbial colonies.
Several studies have already compared this direct AST methods to the current methods used in the laboratory. These direct AST methods using inoculation from PBCs had quite acceptable results for Gram-negative rods, but not for Gram-positive cocci [8, 9, 11, 12, 18] . For higher accuracy of direct AST result for
Gram-positive bacteria, many studies have attempted and chosen methods requiring multiple procedures, such as high speed centrifugation [5] , reagent treatments [19] , short incubation time on solid medium [20] . As a result, accuracy of direct AST results for Gram-positive cocci were quite acceptable with comparable agreement. However, these additional processes are not suitable for clinical application due to laborious works.
The other strategy is the application of novel techniques such as MALDI-TOF mass spectrometry, PCR-based techniques, microarrays, and microfluidics [7] . The QMAC-dRAST system detects the response of individual bacteria to antimicrobials by time-lapse microscopic observation and image analysis of micro-colony formation at the various concentrations of antimicrobial agents [13] .
This study focused on whether the QMAC-dRAST system could be utilized routinely to reduce time for AST results of staphylococci and enterococci by comparing results between QMAC-dRAST system from PBCs and MicroScan WalkAway plus system.
As a result, the QMAC-dRAST system evaluated 1,187 antimicrobial Gram-positive cocci combinations, showing 94.9%
overall CA and 98.3% overall EA, with only 1.0% VME and 1.3% ME. These results indicate that the antimicrobial agreement rate of QMAC-dRAST from PBC with Gram-positive cocci was comparable or superior to that of other studies [9, 12, 21] .
It is noteworthy that the detection of oxacillin-resistant staphylococci with the QMAC-dRAST system was accurate even if one VME was observed in S. aureus, this result agreed with other standard AST reporting for oxacillin-resistance detection, for the agreement rates ranged from 95 to 100% [10, 22] . Also, 
